A prospective study on myocardial injury after BNT162b2 mRNA COVID ‐19 fourth dose vaccination in healthy persons
Abstract
Aims To prospectively evaluate the incidence of myocardial injury after the administration of the fourth dose BNT162b2 mRNA vaccine (Pfizer‐BioNTech) against COVID‐19. Methods and results Health care workers who received the BNT162b2 vaccine during the fourth dose campaign had blood samples collected for high‐sensitivity cardiac troponin (hs‐cTn) during vaccine administration and 2–4 days afterward. Vaccine‐related myocardial injury was defined as hs‐cTn elevation above the 99th percentile upper reference limit and >50% increase from baseline measurement. Participants with evidence of myocardial injury underwent assessment for possible myocarditis. Of 324 participants, 192 (59.2%) were female and the mean age was 51.8 ± 15.0 years. Twenty‐one (6.5%) participants had prior COVID‐19 infection, the mean number of prior vaccine doses was 2.9 ± 0.4, and the median time from the last dose was 147 (142–157) days. Reported vaccine‐related adverse reactions included local pain at injection site in 57 (17.59%), fatigue in 39 (12.04%), myalgia in 32 (9.88%), sore throat in 21 (6.48%), headache in 18 (5.5%), fever ≥38°C in 16 (4.94%), chest pain in 12 (3.7%), palpitations in 7 (2.16%), and shortness of breath in one (0.3%) participant. Vaccine‐related myocardial injury was demonstrated in two (0.62%) participants, one had mild symptoms and one was asymptomatic; both had a normal electrocardiogrammore »
- Authors:
-
- Jesselson Integrated Heart Center, Shaare Zedek Medical Center, Faculty of Medicine The Hebrew University Jerusalem Israel
- Cardiology department Shamir Medical Center Tzrifin Israel
- Clinical Biochemistry Laboratory Shaare Zedek Medical Center Jerusalem Israel
- Infectious Disease Unit, Shaare Zedek Medical Center, Faculty of Medicine The Hebrew University Jerusalem Israel
- Publication Date:
- Sponsoring Org.:
- USDOE
- OSTI Identifier:
- 1889770
- Resource Type:
- Publisher's Accepted Manuscript
- Journal Name:
- European Journal of Heart Failure
- Additional Journal Information:
- Journal Name: European Journal of Heart Failure Journal Volume: 25 Journal Issue: 2; Journal ID: ISSN 1388-9842
- Publisher:
- Wiley Blackwell (John Wiley & Sons)
- Country of Publication:
- Country unknown/Code not available
- Language:
- English
Citation Formats
Levi, Nir, Moravsky, Gil, Weitsman, Tatyana, Amsalem, Itshak, Bar‐Sheshet Itach, Sarit, Algur, Nurit, Lapidus, Ira, Mitz, Ofir, Glikson, Michael, Wiener‐Well, Yonit, and Hasin, Tal. A prospective study on myocardial injury after BNT162b2 mRNA COVID ‐19 fourth dose vaccination in healthy persons. Country unknown/Code not available: N. p., 2022.
Web. doi:10.1002/ejhf.2687.
Levi, Nir, Moravsky, Gil, Weitsman, Tatyana, Amsalem, Itshak, Bar‐Sheshet Itach, Sarit, Algur, Nurit, Lapidus, Ira, Mitz, Ofir, Glikson, Michael, Wiener‐Well, Yonit, & Hasin, Tal. A prospective study on myocardial injury after BNT162b2 mRNA COVID ‐19 fourth dose vaccination in healthy persons. Country unknown/Code not available. https://doi.org/10.1002/ejhf.2687
Levi, Nir, Moravsky, Gil, Weitsman, Tatyana, Amsalem, Itshak, Bar‐Sheshet Itach, Sarit, Algur, Nurit, Lapidus, Ira, Mitz, Ofir, Glikson, Michael, Wiener‐Well, Yonit, and Hasin, Tal. Wed .
"A prospective study on myocardial injury after BNT162b2 mRNA COVID ‐19 fourth dose vaccination in healthy persons". Country unknown/Code not available. https://doi.org/10.1002/ejhf.2687.
@article{osti_1889770,
title = {A prospective study on myocardial injury after BNT162b2 mRNA COVID ‐19 fourth dose vaccination in healthy persons},
author = {Levi, Nir and Moravsky, Gil and Weitsman, Tatyana and Amsalem, Itshak and Bar‐Sheshet Itach, Sarit and Algur, Nurit and Lapidus, Ira and Mitz, Ofir and Glikson, Michael and Wiener‐Well, Yonit and Hasin, Tal},
abstractNote = {Aims To prospectively evaluate the incidence of myocardial injury after the administration of the fourth dose BNT162b2 mRNA vaccine (Pfizer‐BioNTech) against COVID‐19. Methods and results Health care workers who received the BNT162b2 vaccine during the fourth dose campaign had blood samples collected for high‐sensitivity cardiac troponin (hs‐cTn) during vaccine administration and 2–4 days afterward. Vaccine‐related myocardial injury was defined as hs‐cTn elevation above the 99th percentile upper reference limit and >50% increase from baseline measurement. Participants with evidence of myocardial injury underwent assessment for possible myocarditis. Of 324 participants, 192 (59.2%) were female and the mean age was 51.8 ± 15.0 years. Twenty‐one (6.5%) participants had prior COVID‐19 infection, the mean number of prior vaccine doses was 2.9 ± 0.4, and the median time from the last dose was 147 (142–157) days. Reported vaccine‐related adverse reactions included local pain at injection site in 57 (17.59%), fatigue in 39 (12.04%), myalgia in 32 (9.88%), sore throat in 21 (6.48%), headache in 18 (5.5%), fever ≥38°C in 16 (4.94%), chest pain in 12 (3.7%), palpitations in 7 (2.16%), and shortness of breath in one (0.3%) participant. Vaccine‐related myocardial injury was demonstrated in two (0.62%) participants, one had mild symptoms and one was asymptomatic; both had a normal electrocardiogram and echocardiography. Conclusion In a prospective investigation, an increase in serum troponin levels was documented among 0.62% of healthy health care workers receiving the fourth dose BNT162b2 vaccine. The two cases had mild or no symptoms and no clinical sequela. Clinical Trial Registration: ClinicalTrials.gov Identifier: NCT05308680.},
doi = {10.1002/ejhf.2687},
journal = {European Journal of Heart Failure},
number = 2,
volume = 25,
place = {Country unknown/Code not available},
year = {Wed Sep 28 00:00:00 EDT 2022},
month = {Wed Sep 28 00:00:00 EDT 2022}
}
https://doi.org/10.1002/ejhf.2687
Works referenced in this record:
Myocarditis and pericarditis: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data
journal, March 2022
- Sexson Tejtel, S. Kristen; Munoz, Flor M.; Al-Ammouri, Iyad
- Vaccine, Vol. 40, Issue 10
Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study
journal, July 2021
- Menni, Cristina; Klaser, Kerstin; May, Anna
- The Lancet Infectious Diseases, Vol. 21, Issue 7
Elevation of Cardiac Troponin T, But Not Cardiac Troponin I, in Patients With Neuromuscular Diseases
journal, June 2014
- Rittoo, Dylmitr; Jones, Alan; Lecky, Bryan
- Journal of the American College of Cardiology, Vol. 63, Issue 22
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine
journal, December 2021
- Falsey, Ann R.; Sobieszczyk, Magdalena E.; Hirsch, Ian
- New England Journal of Medicine, Vol. 385, Issue 25
Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron
journal, April 2022
- Regev-Yochay, Gili; Gonen, Tal; Gilboa, Mayan
- New England Journal of Medicine, Vol. 386, Issue 14
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months
journal, November 2021
- Thomas, Stephen J.; Moreira, Edson D.; Kitchin, Nicholas
- New England Journal of Medicine, Vol. 385, Issue 19
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
journal, December 2020
- Walsh, Edward E.; Frenck, Robert W.; Falsey, Ann R.
- New England Journal of Medicine, Vol. 383, Issue 25
Biologic Variation of a Novel Cardiac Troponin I Assay
journal, July 2011
- Vasile, Vlad C.; Saenger, Amy K.; Kroning, Jean M.
- Clinical Chemistry, Vol. 57, Issue 7
Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021
journal, January 2022
- Oster, Matthew E.; Shay, David K.; Su, John R.
- JAMA, Vol. 327, Issue 4
Myocarditis after Covid-19 Vaccination in a Large Health Care Organization
journal, December 2021
- Witberg, Guy; Barda, Noam; Hoss, Sara
- New England Journal of Medicine, Vol. 385, Issue 23
Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel
journal, December 2021
- Mevorach, Dror; Anis, Emilia; Cedar, Noa
- New England Journal of Medicine, Vol. 385, Issue 23
Elevated Cardiac Troponin T in Patients With Skeletal Myopathies
journal, April 2018
- Schmid, Johannes; Liesinger, Laura; Birner-Gruenberger, Ruth
- Journal of the American College of Cardiology, Vol. 71, Issue 14
Multicenter analytical evaluation of a high-sensitivity troponin T assay
journal, April 2011
- Saenger, A. K.; Beyrau, R.; Braun, S.
- Clinica Chimica Acta, Vol. 412, Issue 9-10
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
journal, February 2021
- Baden, Lindsey R.; El Sahly, Hana M.; Essink, Brandon
- New England Journal of Medicine, Vol. 384, Issue 5
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
journal, December 2020
- Polack, Fernando P.; Thomas, Stephen J.; Kitchin, Nicholas
- New England Journal of Medicine, Vol. 383, Issue 27
Elevated serum cardiac troponin I in rhabdomyolysis
journal, July 2004
- Punukollu, Gopikrishna; Gowda, Ramesh M.; Khan, Ijaz A.
- International Journal of Cardiology, Vol. 96, Issue 1
Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects?
journal, May 2020
- Caso, Francesco; Costa, Luisa; Ruscitti, Piero
- Autoimmunity Reviews, Vol. 19, Issue 5
Variation of Cardiac Troponin I and T Measured with Sensitive Assays in Emergency Department Patients with Noncardiac Chest Pain
journal, August 2012
- Scharnhorst, Volkher; Krasznai, Krisztina; van 't Veer, Marcel
- Clinical Chemistry, Vol. 58, Issue 8
Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA
journal, August 2005
- Karikó, Katalin; Buckstein, Michael; Ni, Houping
- Immunity, Vol. 23, Issue 2
Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting
journal, September 2021
- Barda, Noam; Dagan, Noa; Ben-Shlomo, Yatir
- New England Journal of Medicine, Vol. 385, Issue 12
Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine
journal, May 2022
- Moreira, Edson D.; Kitchin, Nicholas; Xu, Xia
- New England Journal of Medicine, Vol. 386, Issue 20
Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military
journal, October 2021
- Montgomery, Jay; Ryan, Margaret; Engler, Renata
- JAMA Cardiology, Vol. 6, Issue 10
Determination of 19 Cardiac Troponin I and T Assay 99th Percentile Values from a Common Presumably Healthy Population
journal, November 2012
- Apple, Fred S.; Ler, Ranka; Murakami, MaryAnn M.
- Clinical Chemistry, Vol. 58, Issue 11
Symptomatic Acute Myocarditis in 7 Adolescents After Pfizer-BioNTech COVID-19 Vaccination
journal, September 2021
- Marshall, Mayme; Ferguson, Ian D.; Lewis, Paul
- Pediatrics, Vol. 148, Issue 3
Severe Acute Myocarditis after the Third (Booster) Dose of mRNA COVID-19 Vaccination
journal, April 2022
- Mengesha, Bethlehem; Asenov, Asen G.; Hirsh-Raccah, Bruria
- Vaccines, Vol. 10, Issue 4
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
journal, July 2021
- Gargano, Julia W.; Wallace, Megan; Hadler, Stephen C.
- MMWR. Morbidity and Mortality Weekly Report, Vol. 70, Issue 27
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
journal, July 2013
- Caforio, A. L. P.; Pankuweit, S.; Arbustini, E.
- European Heart Journal, Vol. 34, Issue 33
A Case Series of Myocarditis Following Third (Booster) Dose of COVID-19 Vaccination: Magnetic Resonance Imaging Study
journal, March 2022
- Shiyovich, Arthur; Witberg, Guy; Aviv, Yaron
- Frontiers in Cardiovascular Medicine, Vol. 9